3.50MMarket Cap-621P/E (TTM)
0.508High0.460Low105.86KVolume0.508Open0.531Pre Close51.35KTurnover2.20%Turnover RatioLossP/E (Static)7.61MShares2.71052wk High1.37P/B2.21MFloat Cap0.40052wk Low--Dividend TTM4.81MShs Float7.720Historical High--Div YieldTTM9.06%Amplitude0.400Historical Low0.485Avg Price1Lot Size
Lipella Pharmaceuticals Stock Forum
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
PITTSBURGH, May 31, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the successful completion of its first Site Initiation Visit (SIV) for the Phase 2a trial evalua...
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
3 MINUTES AGO, 8:00 AM EST
VIA GLOBENEWSWIRE
$Lipella Pharmaceuticals(LIPO.US)$
double bottom?
$XBP Europe Holdings(XBP.US)$
$Volato Group(SOAR.US)$
$Meiwu Technology(WNW.US)$
$Lipella Pharmaceuticals(LIPO.US)$ Lipella
No comment yet